The Collateral Impacts of Pandemic
Keywords:
COVID-19, impact, collateral, pandemic, IndonesiaAbstract
A pandemic that covers the whole world occurs relatively in every 100 years. Thus, it can be said that no expert has ever experienced directly dealing with a global pandemic. In the absence of people who are truly experts who know the problems and impacts of a global pandemic, various studies need to be carried out extensively between fields and across regions in the world. Likewise, the results of the study need to be recorded permanently so that it can still be useful over a long period of time, preferably for more than a hundred years.Studies of the short-term and long-term impacts of the pandemic on things other than mortality are calling us to be worked upon. It is the time for us to be concerned with the risk assessment of benefits before a decision is taken and its openly scientific reporting. It is necessary to develop strategies to mitigate or avoid dire consequences of a policy. Until now, studies of health policy on the vulnerable group seem to be minimally done. It would be wise to encourage more studies to groups that are vulnerable to the impact of a policy.The collateral impacts of the pandemic do not only affect the health services on diseases other than Covid-19, but also includes the collateral impact of humanitarian threats in other fields. Management of a global pandemic needs to be carried out comprehensively, both in handling the disease, support for and access to other diseases, as well as collaboration and socioeconomic policies that maintain the pillars of humanity. Lessons must be taken by humans in order to defend their race in the future, including pandemics that occur repeatedly over a span that is longer than the age of three generations.References
Tisdell CA. Economic, social and political issues raised by the COVID-19 pandemic. Econ Anal Policy. 2020;68:17-28. doi:10.1016/j.eap.2020.08.002.
World Health Organization. COVID-19 significantly impacts health services for non-communicable diseases [Internet]. Geneva: World Health Organization [updated 2020 Jun 1; cited 2020 Dec 18]. Available from: https://www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases.
Bavli I, Sutton B, Galea S. Harms of public health interventions against covid-19 must not be ignored. BMJ. 2020 Nov 2;371:m4074. doi: 10.1136/bmj.m4074.
Hogan AB, Jewell BL, Sherrard-Smith E. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020. doi: 10.1016/S2214-109X(20)30288-6. published online July 13.
Puras D. Public health policy shapes COVID-19 impact: UN expert’s final report. 2020 Oct 13. Retrieved December 18, 2020, from https://www.hhrjournal.org/2020/10/public-health-policy-shapes-covid-19-impact-un-experts-final-report/.
Magfira N, Helda. Correlation between adult tobacco smoking prevalence and mortality of Coronavirus Disease-19 across the world. Acta Med Indones. 2020;52(4):318-25.
Bambra C, Riordan R, Ford J, Matthews F. The COVID-19 pandemic and health inequalities. J Epidemiol Community Health. 2020 Nov;74(11):964-968. doi: 10.1136/jech-2020-214401. Epub 2020 Jun 13. PMID: 32535550; PMCID: PMC7298201.
Bong CL, Brasher C, Chikumba E, McDougall R, Mellin-Olsen J, Enright A. The COVID-19 pandemic: Effects on low- and middle-income countries. Anesth Analg. 2020;131(1):86-92. doi:10.1213/ANE.0000000000004846.
Andriani H. Effectiveness of large-scale social restrictions (PSBB) toward the new normal era during COVID-19 outbreak: a mini policy review. J Indones Health Policy Admin. 2020;5(2). doi:10.7454/ihpa.v5i2.4001.
Schneider M, Eide AH, Amin M, MacLachlan M, Mannan H. Inclusion of vulnerable groups in health policies: Regional policies on health priorities in Africa. Afr J Disabil. 2013;2(1):40. Published 2013 Jan 22. doi:10.4102/ajod.v2i1.40.
Javaid M, Haleem A, Vaishya R, Bahl S, Suman R, Vaish A. Industry 4.0 technologies and their applications in fighting COVID-19 pandemic. Diabetes Metab Syndr. 2020;14(4):419-422. doi:10.1016/j.dsx.2020.04.032.
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
